TTK Healthcare profit and loss

Latest FY26

Revenue: ₹857cr+7.0% on FY25
EBITDA: ₹26.2cr−24.8% on FY25
Net profit: ₹65.7cr−19.6% on FY25
EPS: ₹46.48−19.6% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	918	857	801	753	725	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	70.7	72.2	71.3	62.6	48.3
	989	929	873	815	773
	232	200	195	173	182
	209	203	187	176	170
	−9.1	−0.1	−13.4	−10.6	−4.7
	176	165	151	133	123
	2.4	2.9	3.3	2.8	5.2
	8.7	8.8	8.3	13.1	12.8
	274	262	247	244	223
	893	843	778	731	712
	36.6	26.2	34.8	37.3	31.3
	28.0	17.4	26.5	24.3	18.5
Profit
	96.3	86.6	94.4	84.1	61.6
	244	−4.1	13.9	0.0	0.0
	340	82.6	108	84.1	61.6
	64.2	17.3	26.6	22.1	17.4
	−0.3	−0.4	0.1	−0.8	−0.4
	63.9	16.9	26.7	21.3	17.0
	277	65.7	81.7	62.8	640
	277	65.7	81.7	62.8	44.7
	0.0	0.0	0.0	0.0	595
	−1.0	−1.7	−3.4	−1.2	−1.8
	276	63.9	78.3	61.7	638
Per share
	₹195.71	₹46.48	₹57.79	₹44.47	₹452.72
	₹195.71	₹46.48	₹57.79	₹44.47	₹452.72
Continuing & discontinued operations
	0.0	0.0	0.0	0.0	776
	0.0	0.0	0.0	0.0	181
Other comprehensive income — detail
	−1.0	−1.7	−3.4	—	—
	−0.6	−1.5	−4.0	−1.4	−2.0
	0.3	0.3	−0.6	—	—
	—	—	—	−0.3	−0.1
	—	—	—	−1.4	−2.0
	—	—	—	0.3	0.1
Per share — as-filed variants
	₹195.71	₹46.48	₹57.79	₹44.47	₹31.61
	₹195.71	₹46.48	₹57.79	₹44.47	₹31.61
	₹0.00	₹0.00	₹0.00	₹0.00	₹421.11
	₹0.00	₹0.00	₹0.00	₹0.00	₹421.11
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	487	454	433	415	377
	53.0%	52.9%	54.0%	55.1%	52.0%
Adjusted (ex-exceptional items) — derived
	96.3	86.6	94.4	84.1	61.6
	244	−4.1	13.9	0.0	0.0
	78.2	68.9	71.2	62.8	640
	₹55.36	₹48.77	₹50.37	₹44.47	₹452.72

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

TTKHLTCARE₹980.00

TTK Healthcare Limited

· Others

Annual Quarterly₹ CrorePeersDCMSHRIRAM BALMLAWRIE GODREJIND 3MINDIAMcap ₹1,385 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	725.1	752.8	801.5	857.3	918.2
Other Income	48.3	62.6	71.3	72.2	70.7
Total Income	773.4	815.4	872.7	929.4	989.0
Expenses
+ Cost of Materials Consumed	182.3	173.3	195.3	200.5	231.6
+ Purchases of Stock-in-Trade	170.2	175.6	186.9	203.1	209.3
+ Changes in Inventories	-4.7	-10.6	-13.4	-0.1	-9.1
+ Employee Benefit Expense	123.4	132.8	150.9	165.2	175.7
+ Finance Costs	5.2	2.8	3.3	2.9	2.4
+ Depreciation & Amortisation	12.8	13.1	8.3	8.8	8.7
+ Other Expenses	222.6	244.4	246.8	262.5	274.1
Total Expenses	711.8	731.3	778.3	842.8	892.7
EBITDA	31.3	37.3	34.8	26.2	36.6
EBIT	18.5	24.3	26.5	17.4	28.0
Profit
PBT before Exceptional Items	61.6	84.1	94.4	86.6	96.3
+ Exceptional Items	0.0	0.0	13.9	-4.1	244.1
Pretax Income	61.6	84.1	108.3	82.6	340.4
+ Current Tax	17.4	22.1	26.6	17.3	64.2
+ Deferred Tax	-0.4	-0.8	0.1	-0.4	-0.3
Tax Expense	17.0	21.3	26.7	16.9	63.9
Net Income	639.7	62.8	81.7	65.7	276.5
+ Net Income — Continuing Ops	44.7	62.8	81.7	65.7	276.5
+ Net Income — Discontinued Ops	595.0	0.0	0.0	0.0	0.0
+ Other Comprehensive Income	-1.8	-1.2	-3.4	-1.7	-1.0
Total Comprehensive Income	637.9	61.7	78.3	63.9	275.6
Per Share
Basic EPS	452.72	44.47	57.79	46.48	195.71
Diluted EPS	452.72	44.47	57.79	46.48	195.71
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	776.4	0.0	0.0	0.0	0.0
+ Tax — Discontinued Operations	181.4	0.0	0.0	0.0	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-3.4	-1.7	-1.0
+ Items NOT to be Reclassified to P&L	-2.0	-1.4	-4.0	-1.5	-0.6
+ Tax on Items NOT to be Reclassified	—	—	-0.6	0.3	0.3
+ Tax on Items NOT to be Reclassified — alt tag	-0.1	-0.3	—	—	—
Comprehensive Income — Owners of Parent	-2.0	-1.4	—	—	—
Comprehensive Income — Non-controlling Interests	0.1	0.3	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	31.61	44.47	57.79	46.48	195.71
Diluted EPS — Continuing Operations	31.61	44.47	57.79	46.48	195.71
Basic EPS — Discontinued Operations	421.11	0.00	0.00	0.00	0.00
Diluted EPS — Discontinued Operations	421.11	0.00	0.00	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	377.3	414.5	432.6	453.8	486.5
Gross Margin %	52.04	55.07	53.97	52.93	52.98
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	61.6	84.1	94.4	86.6	96.3
− Exceptional Items (reconciliation)	0.0	0.0	13.9	-4.1	244.1
Net Income Adj (tax-effected)	639.7	62.8	71.2	68.9	78.2
EPS Adj	452.72	44.47	50.37	48.77	55.36
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	14.1	14.1	14.1	14.1	14.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.